We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Trial of Health at Work Workplace Health Intervention (H@W)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00858533
First Posted: March 10, 2009
Last Update Posted: July 28, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University of Liverpool
  Purpose
This pilot study will compare workplace health intervention delivered by advisors based in GP practices with normal GP care to assess the usefulness of the concept and its potential for wider use in a larger randomised controlled trial.

Condition Intervention
Workplace Health Behavioral: Health at Work workplace health advice and support

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: A Pilot Controlled Feasibility Trial of Early Health at Work Workplace Intervention

Further study details as provided by University of Liverpool:

Primary Outcome Measures:
  • Number of days off work through sickness absence after index consultation, which will also apply to people at work with a work-relevant condition [ Time Frame: 1 year ]

Secondary Outcome Measures:
  • Secondary outcome measure: time to first return to work (RTW) allowing for phased return. [ Time Frame: 1 year ]

Enrollment: 63
Study Start Date: June 2008
Study Completion Date: March 2010
Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
workplace health advice
The intervention group will receive additional support from a H@W Workplace Health Advisor who will deliver an intervention aimed at sickness absence prevention or sustained return to work, depending on individual circumstances.
Behavioral: Health at Work workplace health advice and support
The intervention group will receive additional support from a H@W Workplace Health Advisor who will deliver an intervention aimed at sickness absence prevention or sustained return to work, depending on individual circumstances. The intervention will be standardized as far as possible to show types of activity undertaken with participants, their GP, line managers, human resources departments and trade union representatives.
No Intervention: GP sickness absence consultation
Routine general practitioner care for workplace sickness absence.
Behavioral: Health at Work workplace health advice and support
The intervention group will receive additional support from a H@W Workplace Health Advisor who will deliver an intervention aimed at sickness absence prevention or sustained return to work, depending on individual circumstances. The intervention will be standardized as far as possible to show types of activity undertaken with participants, their GP, line managers, human resources departments and trade union representatives.

Detailed Description:

The aim of this pilot study is to examine the impact of H@W intervention(s) on job retention and return to work and compare outcomes with those from normal GP care. The target population for this study is people still at work but experiencing a work-related health problem as well as those off work. For the purpose of the study, short term sickness absence is defined as a period of 4 weeks or less and long term sickness absence defined as a period of 4 weeks or longer. Hypothesis

That H@W intervention in comparison to standard care:

  • promotes work retention
  • enables a quick and sustained return to work for those on short term sick leave (4 weeks or less)
  • achieves sustained return to work for those on long term sick leave of 4 weeks or more. This could include a phased return to work.
  • achieves positive outcomes which could mean leaving one job and starting another.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • People with work related health problems registered with GP practices in Liverpool Primary Care Trust.

Exclusion Criteria:

  • People registered with GP practices outside Liverpool Primary Care Trust.
  • Vulnerable adults and those considered by their GP to be unsuitable for the trial.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00858533


Locations
United Kingdom
Division of Primary Care, University of Liverpool.
Liverpool, Merseyside, United Kingdom, L69 3GB
Sponsors and Collaborators
University of Liverpool
Investigators
Principal Investigator: Mark B Gabbay, MD University of Liverpool
  More Information

Responsible Party: Professor Mark Gabbay, University of Liverpool
ClinicalTrials.gov Identifier: NCT00858533     History of Changes
Other Study ID Numbers: BER10457
First Submitted: March 9, 2009
First Posted: March 10, 2009
Last Update Posted: July 28, 2010
Last Verified: January 2010

Keywords provided by University of Liverpool:
early intervention
sickness absence
return to work
primary care